| dc.contributor | Consorci Sanitari de Terrassa |
| dc.contributor.author | Plaza Diaz, Adrian |
| dc.contributor.author | Juanes Borrego, Ana |
| dc.contributor.author | Sanz-Lopez, Natalia |
| dc.contributor.author | González Bueno, Javier |
| dc.contributor.author | Fernández-Morató, Jordi |
| dc.contributor.author | Garcia-Pelaez, Milagros |
| dc.date.accessioned | 2025-10-27T13:44:32Z |
| dc.date.available | 2025-10-27T13:44:32Z |
| dc.date.issued | 2025-09-29 |
| dc.identifier.citation | Plaza-Díaz A, Juanes-Borrego A, Sanz-Lopez N, González-Bueno J, Fernández-Morató J, García-Peláez M, et al. Emergency Department Reconsultations After a Secondary Prevention Bundle for Medication-Related Problems: A Retrospective Cohort Study. J Clin Med. 2025 Sep 29;14(19):6907. |
| dc.identifier.issn | 2077-0383 |
| dc.identifier.uri | http://hdl.handle.net/11351/13942 |
| dc.description | Drug-related problems; Emergency department; Older adults; Readmission; Secondary prevention |
| dc.description.abstract | Background/Objective: Drug-related problems (DRPs) are a common, potentially avoidable cause of emergency department (ED) use. In December 2022, our hospital integrated a pharmacist-led intervention into routine ED practice. This intervention comprised medication optimization, adherence counseling, and coordinated hand-off to primary care. We quantified 30- and 90-day reconsultations after discharge and explored factors associated with DRP-related revisits. Methods: A retrospective cohort of adults (≥18 years) who attended a tertiary ED (Barcelona, Spain). We included index DRP visits from 1 December 2022 to 30 June 2024. All received the bundle. Demographic, clinical, and pharmacotherapeutic data were extracted from the Catalan Shared Health Record; an independent committee classified revisits as a DRP or non-DRP. Predictors of 30-day DRP revisits were assessed with multivariable logistic regression. Results: Among 1247 patients (mean age 78.6 ± 16.2 years; 59.2% women; and median nine drugs), 120 (9.6%) reconsulted the ED within 30 days, and 194 (15.5%) within 90 days for any cause. DRP-specific rates were 30.8% (37/120) at 30 days and 26.3% (51/194) at 90 days; 81% and 80% of these revisits, respectively, involved a recurrence of the same DRP. The most frequent index DRPs were constipation (14.2%), gastrointestinal bleeding (9.2%), hypertension (8.3%), seizures (8.3%) and hyponatraemia (6.7%). An age ≥ 80 years independently predicted fewer 30-day DRP revisits (OR 0.32; 95% CI 0.13-0.79); hypertension and cognitive impairment were not significant after adjustment. Conclusions: In this single-arm implementation cohort, overall, 30-day ED reconsultations were 9.6% and about one-third were DRP-related, predominantly recurrences, and chiefly gastrointestinal bleeding and seizures. These descriptive findings should be interpreted cautiously given potential survivorship bias and residual confounding; the apparently lower risk among patients aged ≥ 80 years is hypothesis-generating and may reflect geriatric care pathways and caregiver engagement. Targeted post-discharge monitoring for high-recurrence DRPs may help reduce avoidable ED use, and future evaluations should test this in quasi-experimental or randomized designs. |
| dc.language.iso | eng |
| dc.publisher | MDPI |
| dc.relation.ispartofseries | Journal of clinical medicine;14(19) |
| dc.rights | Attribution-NonCommercial 4.0 International |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | Hospitals - Serveis d'urgències |
| dc.subject | Medicaments - Efectes secundaris |
| dc.subject | Raonament basat en casos |
| dc.subject.mesh | Emergency Medical Services |
| dc.subject.mesh | Drug-Related Side Effects and Adverse Reactions |
| dc.subject.mesh | Cohort Studies |
| dc.title | Emergency Department Reconsultations After a Secondary Prevention Bundle for Medication-Related Problems: A Retrospective Cohort Study |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.3390/jcm14196907 |
| dc.subject.decs | servicios médicos de urgencia |
| dc.subject.decs | efectos colaterales y reacciones adversas relacionados con medicamentos |
| dc.subject.decs | estudios de cohortes |
| dc.relation.publishversion | https://www.doi.org/10.3390/jcm14196907 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.authoraffiliation | [Plaza-Díaz A] Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain. Department of Medicine, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. [Juanes-Borrego A] Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain. [Sanz-Lopez N] Emergency Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [González-Bueno J] Pharmacy Department, Hospital Dos de Maig Consorci Sanitari Integral, Barcelona, Spain. Central Catalonia Chronicity Research Group (C3RG), University of Vic-Central University of Catalonia (UVIC-UCC), Vic, Spain. [Fernández-Morató J] Pharmacy Department, Consorci Sanitari de Terrassa, Terrassa, Spain. [García-Peláez M] Pharmacy Department, Hospital General de Granollers, Granollers, Spain |
| dc.identifier.pmid | 41095987 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |